NCT02781857View on ClinicalTrials.gov

Mass Spectral Fingerprinting in Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

393

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2024

Study Completion Date

March 31, 2025

Conditions
Lung Cancer
Interventions
OTHER

No intervention

Trial Locations (1)

8091

University Hospital Zurich, Division of Pneumology, Zurich

All Listed Sponsors
collaborator

Swiss Federal Institute of Technology

OTHER

lead

University of Zurich

OTHER

NCT02781857 - Mass Spectral Fingerprinting in Lung Cancer | Biotech Hunter | Biotech Hunter